Skip to main content
OpenTrials
Completed

NCT Number: NCT03632057

Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Implantable-Cardioverter Population

This is a prospective, 1:1 randomized, interventional, multicenter and international trial. Approximately 790 subjects are expected to be enrolled to 40 sites in the south of Europe and Middle East.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Virgen de la Victoria, Málaga, Andalusia, Spain

Loading trial locations.

About this study

The objective of this study is to evaluate and compare the efficacy of the first appropriate shock of an ICD in a ventricular tachyarrhythmia, when the waveform of the shock is programmed with the standard waveform, Fixed Tilt with a value of 65% (Control Group), versus the exclusive waveform programmable in SJM ICDs, Fixed Pulse Width (Study Group), in a standard population of subjects with ICD indication.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who meet the current ESC indications for ICD or CRT-D implant. This includes upgrades indications from pacemaker to ICD or to CRT-D or replacements of ICDs or CRT-Ds provided that there is no previous record of ineffective shocks
  • Subjects who are willing to be registered on the Merlin.net remote follow-up program
  • Subject ≥18 years
  • Subjects with life expectancy of at least 1 year
  • Subjects who agree to comply with the follow-up program included in this protocol

Exclusion criteria

  • • Subjects on the waiting list for a heart transplant or under consideration for a transplant over the next 12 months
  • Subjects with Myocardial infarction or unstable angina within 40 days prior to enrollment
  • Subjects who have undergone a recent cardiac revascularization (PTCA, Stent or CABG) procedure in the 4 weeks prior to enrollment
  • Functional NYHA Class IV
  • Subjects who are participating in another ICD or CRT-D study
  • Subjects who are pregnant at the time of enrollment or women of childbearing potential that do not take contraceptives
  • Any disability or limitations to correctly understand or complete the study (physical, intellectual, logistical)

Treatment and study plan

Fixed Tilt (65%)

Device

This is the standard group, so device programming for shock energy is the default setting

Fixed Pulse Width

Device

The device has to be programmed with fixed pulse width for each phase of the biphasic waveform

Primary outcomes

  1. Efficacy of the first appropriate shock to revert a tachyarrhythmia to sinus rhythm

    Time frame: 5 years

    Rate of rhythm conversion from Ventricular Tachyarrhythmia to sinus rhythm by the first appropriate shock programmed to 25 Joules (or equivalent voltage) programming the shock waveform in Fixed Pulse Width (Study Group) versus the Fixed Tilt with value 65% (Control Group).

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Official study title

Shock Efficacy, a Randomized Study Comparing Fixed Tilt and Fixed Pulse Width in a General Implantable-Cardioverter Population

Acronym: EFICAZ

Important dates

Study start
2018
Primary completion
2025
Study completion
2025
First posted
Aug 15, 2018
Registry last updated
May 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.